LifeStance Health Group, Inc. (LFST) Misses Q3 EPS by 11c

Go back to LifeStance Health Group, Inc. (LFST) Misses Q3 EPS by 11c

JPMorgan Downgrades Lifestance Health Group (LFST) to Neutral

November 9, 2021 6:59 AM EST

JPMorgan analyst Lisa Gill downgraded Lifestance Health Group (NASDAQ: LFST) from Overweight to Neutral with a price target of $12.00 (from $24.00).

The analyst comments "We are downgrading shares of LifeStance Health to Neutral from Overweight and lowering our Dec-22 price target to $12 from $24. LFST... More